Skip to main content

Table 2 Preoperative blood parameters of patients with renal cell carcinoma and tumour thrombus treated surgically

From: Preoperative anaemia and thrombocytosis predict adverse prognosis in non‐metastatic renal cell carcinoma with tumour thrombus

Blood parameters (unit)

Median (IQR)

NEU (× 109/L)

4.31 (3.53–5.04)

LYM(× 109/L)

1.29 (1–1.62)

PLT (× 109/L)

235 (185.25–299)

HGB (g/L)

123 (111–139)

ALB (g/L)

40 (35.55–43.05)

SCR (umol/L)

89.5 (80–108.5)

ALT (u/L)

16 (11.75–26.25)

AST(u/L)

18 (15–24)

SCa (mmol/L)

2.28 (2.18–2.38)

ALP (u/L)

80 (65–101)

NLR

3.43 (2.39–4.49)

PLR

184.81 (118.89–273.57)

AST/ALT

1.13 (0.83–1.45)

  1. NEU neutrophil count, LYM lymphocyte count, PLT platelet count, HGB hemoglobin, ALB albumin, SCR serum creatinine, SCa serum calcium, ALP alkaline phosphatase